290 related articles for article (PubMed ID: 26341250)
1. Plasma levels of oxidative stress in children with steroid-sensitive nephrotic syndrome and their predictive value for relapse frequency.
Fan A; Jiang X; Mo Y; Tan H; Jiang M; Li J
Pediatr Nephrol; 2016 Jan; 31(1):83-8. PubMed ID: 26341250
[TBL] [Abstract][Full Text] [Related]
2. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
3. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.
El-Melegy NT; Mohamed NA; Sayed MM
Pediatr Res; 2008 Apr; 63(4):404-9. PubMed ID: 18356747
[TBL] [Abstract][Full Text] [Related]
4. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome.
Holt RC; Webb NJ; Ralph S; Davies J; Short CD; Brenchley PE
Kidney Int; 2005 Jan; 67(1):122-9. PubMed ID: 15610235
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between the serum level of advanced oxidation protein products and the cognitive function in patients with obstructive sleep apnea hypopnea syndrome].
Yang XH; Liu X; Shang J; Liu HG; Xu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):274-9. PubMed ID: 23945341
[TBL] [Abstract][Full Text] [Related]
6. Oxidant stress in primary nephrotic syndrome: does it modulate the response to corticosteroids?
Bakr A; Abul Hassan S; Shoker M; Zaki M; Hassan R
Pediatr Nephrol; 2009 Dec; 24(12):2375-80. PubMed ID: 19644712
[TBL] [Abstract][Full Text] [Related]
7. Advanced oxidation protein products and malondialdehyde - the new biological markers of oxidative stress - are elevated in postmenopausal women.
Cakir T; Goktas B; Mutlu MF; Mutlu I; Bilgihan A; Erdem M; Erdem A
Ginekol Pol; 2016; 87(5):321-5. PubMed ID: 27304645
[TBL] [Abstract][Full Text] [Related]
8. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
Fakhouri F; Bocquet N; Taupin P; Presne C; Gagnadoux MF; Landais P; Lesavre P; Chauveau D; Knebelmann B; Broyer M; Grünfeld JP; Niaudet P
Am J Kidney Dis; 2003 Mar; 41(3):550-7. PubMed ID: 12612977
[TBL] [Abstract][Full Text] [Related]
9. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
[TBL] [Abstract][Full Text] [Related]
10. Frequency of relapse among Nigerian children with steroid-sensitive nephrotic syndrome.
Esezobor CI; Ladapo TA; Lesi FE
Niger J Clin Pract; 2016; 19(2):254-8. PubMed ID: 26856291
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in pediatric nephrotic syndrome.
Kamireddy R; Kavuri S; Devi S; Vemula H; Chandana D; Harinarayanan S; James R; Rao A
Clin Chim Acta; 2002 Nov; 325(1-2):147-50. PubMed ID: 12367779
[TBL] [Abstract][Full Text] [Related]
12. An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer.
Kilic N; Yavuz Taslipinar M; Guney Y; Tekin E; Onuk E
Ann Surg Oncol; 2014 Dec; 21(13):4139-43. PubMed ID: 24962940
[TBL] [Abstract][Full Text] [Related]
13. Urinary Sediment mRNA Level of CREBBP and CYBA in Children With Steroid-Resistant Nephrotic Syndrome.
Li W; Shou X; Xiang W; He L; Li L; Fu H; Mao J
Front Immunol; 2021; 12():801313. PubMed ID: 35173708
[TBL] [Abstract][Full Text] [Related]
14. Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis.
Obradovic D; Andjelic T; Ninkovic M; Dejanovic B; Kotur-Stevuljevic J
Neurol Sci; 2021 Aug; 42(8):3241-3247. PubMed ID: 33241537
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress status in children with nephrotic syndrome.
Rajbala A; Sane AS; Zope J; Mishra VV; Trivedi HL
Panminerva Med; 1997 Sep; 39(3):165-8. PubMed ID: 9360415
[TBL] [Abstract][Full Text] [Related]
16. Malondialdehyde and advanced oxidation protein products are not increased in psoriasis: a controlled study.
Skoie IM; Dalen I; Omdal R; Jonsson G
Arch Dermatol Res; 2019 May; 311(4):299-308. PubMed ID: 30830309
[TBL] [Abstract][Full Text] [Related]
17. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant status of children with idiopathic nephrotic syndrome.
Mishra OP; Gupta AK; Prasad R; Ali Z; Upadhyay RS; Mishra SP; Tiwary NK; Schaefer FS
Pediatr Nephrol; 2011 Feb; 26(2):251-6. PubMed ID: 21104098
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus vaccination in children with steroid sensitive nephrotic syndrome: immunogenicity and safety?
Yıldız N; Sever L; Kasapçopur Ö; Çullu F; Arısoy N; Çalışkan S
Vaccine; 2013 Jul; 31(33):3309-12. PubMed ID: 23684838
[TBL] [Abstract][Full Text] [Related]
20. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
Larkins N; Kim S; Craig J; Hodson E
Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
